The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

These include: high blood pressure (hypertension) diabetes irregular and fast heartbeats (atrial fibrillation) high cholesterol a transient ischaemic attack (TIA or mini stroke) If you have ...

Hidden warning signs of serious health issues like diabetes and high blood pressure could be lying undetected in your eyes. However, a pioneering test now available at Boots Opticians might offer ...

Good blood pressure control can prevent “major cardiovascular events” among people living with type 2 diabetes, a new study has claimed ... group were 21% less likely to develop cardiovascular disease ...

Early warning signs of diabetes, high blood pressure, and other chronic diseases could be lurking in the back of your eye before symptoms start to show. However, a new test at Boots Opticians ...

Lean meats are a better choice for a balanced diet. People who have diabetic nephropathy, which is a kidney disease related to diabetes, often need to eat less protein. In this case, the recommended ...

People with diabetes may also develop high blood pressure, which can lead to kidney damage. “Hypertension by itself is one of the main causes of kidney disease,” Shafipour said. “There’s a ...

With the FDA's approval, the medicine, chemically known as semaglutide, will become the first GLP-1 treatment option for persons with type 2 diabetes and chronic kidney disease. “Such an ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

A Phase 3 clinical trial found that injections of the semaglutide medication once weekly reduced the risk of kidney disease worsening by 24% in people who also had diabetes. It also reduced the ...